View in EDS

Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting.

Saved in:
Bibliographic Details
Title: Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting.
Authors: Rosar, Florian1 (AUTHOR), Khreish, Fadi1,2 (AUTHOR), Burgard, Caroline1 (AUTHOR), Fursov, Artyom1 (AUTHOR), Blickle, Arne1 (AUTHOR), Bartholomä, Mark1 (AUTHOR), Maus, Stephan1 (AUTHOR), Bastian, Moritz B.1 (AUTHOR), Speicher, Tilman1 (AUTHOR), Schaefer-Schuler, Andrea1 (AUTHOR), Ezziddin, Samer1,3 (AUTHOR) samer.ezziddin@uks.eu
Source: European Journal of Nuclear Medicine & Molecular Imaging. Apr2026, Vol. 53 Issue 5, p3034-3041. 8p.
Database: Academic Search Ultimate
Description
ISSN:16197070
DOI:10.1007/s00259-025-07682-5